Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ivan Caramanna"'
Autor:
Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J.B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein
Publikováno v:
European Journal of Cancer, 186, 38-51. Elsevier Ltd.
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
Background: Patients’ reduced awareness of neurocognitive functioning (NCF) may negatively affect the reliability of patient-reported outcomes (PROs) and clinical decision-making. This study evaluated cognitive awareness, defined as the association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcfe21286f4a68f06eb751e3ad7f996
https://doi.org/10.1016/j.ejca.2023.02.029
https://doi.org/10.1016/j.ejca.2023.02.029
Autor:
Ivan Caramanna, Julie M de Kort, Alba A Brandes, Walter Taal, Michael Platten, Ahmed Idbaih, Jean Sebastien Frenel, Wolfgang Wick, Chandrakanth Jayachandran Preetha, Martin Bendszus, Philipp Vollmuth, Jaap C Reijneveld, Martin Klein
Publikováno v:
Neuro-Oncology Practice, 9(4), 310-316. Oxford University Press
Caramanna, I, de Kort, J M, Brandes, A A, Taal, W, Platten, M, Idbaih, A, Frenel, J S, Wick, W, Preetha, C J, Bendszus, M, Vollmuth, P, Reijneveld, J C & Klein, M 2022, ' Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma : Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101 ', Neuro-Oncology Practice, vol. 9, no. 4, pp. 310-316 . https://doi.org/10.1093/nop/npac022
Caramanna, I, de Kort, J M, Brandes, A A, Taal, W, Platten, M, Idbaih, A, Frenel, J S, Wick, W, Preetha, C J, Bendszus, M, Vollmuth, P, Reijneveld, J C & Klein, M 2022, ' Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma : Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101 ', Neuro-Oncology Practice, vol. 9, no. 4, pp. 310-316 . https://doi.org/10.1093/nop/npac022
Background In patients with recurrent glioblastoma, corticosteroids are frequently used to mitigate intracranial pressure and to improve patient neurological functioning. To date, in these patients, no systematic studies have been performed to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2c28b8c5f8c59785ef305e12fec0bb
http://www.scopus.com/inward/record.url?scp=85135757142&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85135757142&partnerID=8YFLogxK
Autor:
Martin J. van den Bent, Martin Klein, Andrew Bottomley, Wolfgang Wick, Jos W. R. Twisk, Jaap C. Reijneveld, A Josephine Drijver, Ahmed Idbaih, Madeline Pe, Ivan Caramanna
Publikováno v:
European Journal of Cancer, 144, 162-168. Elsevier Ltd.
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 144, pp.162-168. ⟨10.1016/j.ejca.2020.10.040⟩
European Journal of Cancer, 144, 162-168. Elsevier Limited
European Journal of Cancer, 144, 162-168. Pergamon
European Journal of Cancer, 2020, 144, pp.162-168. ⟨10.1016/j.ejca.2020.10.040⟩
Caramanna, I, Bottomley, A, Drijver, A J, Twisk, J, van den Bent, M, Idbaih, A, Wick, W, Pe, M, Klein, M, Reijneveld, J C & EORTC Quality of Life Group and Brain Tumour Group 2021, ' Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma : Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials ', European Journal of Cancer, vol. 144, pp. 162-168 . https://doi.org/10.1016/j.ejca.2020.10.040
EORTC Quality of Life Group and Brain Tumour Group 2021, ' Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma : Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials ', European Journal of Cancer, vol. 144, pp. 162-168 . https://doi.org/10.1016/j.ejca.2020.10.040
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 144, pp.162-168. ⟨10.1016/j.ejca.2020.10.040⟩
European Journal of Cancer, 144, 162-168. Elsevier Limited
European Journal of Cancer, 144, 162-168. Pergamon
European Journal of Cancer, 2020, 144, pp.162-168. ⟨10.1016/j.ejca.2020.10.040⟩
Caramanna, I, Bottomley, A, Drijver, A J, Twisk, J, van den Bent, M, Idbaih, A, Wick, W, Pe, M, Klein, M, Reijneveld, J C & EORTC Quality of Life Group and Brain Tumour Group 2021, ' Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma : Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials ', European Journal of Cancer, vol. 144, pp. 162-168 . https://doi.org/10.1016/j.ejca.2020.10.040
EORTC Quality of Life Group and Brain Tumour Group 2021, ' Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma : Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials ', European Journal of Cancer, vol. 144, pp. 162-168 . https://doi.org/10.1016/j.ejca.2020.10.040
BACKGROUND: Neurocognitively impaired patients with brain tumour are presumed to have reduced cognitive awareness preventing them from adequately valuing and reporting their own functioning, for instance, when providing patient-reported outcomes (PRO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32934e2433aa78b6946c1788036d1437
https://doi.org/10.1016/j.ejca.2020.10.040
https://doi.org/10.1016/j.ejca.2020.10.040